Trifluoroacetic acid → HCID 89630059, compound
Reaction equation
[S:1]1[CH:5]=[CH:4][N:3]=[C:2]1[C:6]1[C:14]2[C:13]([C:15]3[CH:16]=[C:17]([NH:21][C:22](=[O:26])[C:23]([CH3:25])=[CH2:24])[CH:18]=[CH:19][CH:20]=3)=[N:12][CH:11]=[N:10][C:9]=2[N:8](COCC[Si](C)(C)C)[CH:7]=1.C(O)(C(F)(F)F)=O>C(Cl)Cl.CO.CCOC(C)=O>[S:1]1[CH:5]=[CH:4][N:3]=[C:2]1[C:6]1[C:14]2[C:13]([C:15]3[CH:16]=[C:17]([NH:21][C:22](=[O:26])[C:23]([CH3:25])=[CH2:24])[CH:18]=[CH:19][CH:20]=3)=[N:12][CH:11]=[N:10][C:9]=2[NH:8][CH:7]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 3
Procedure
To a solution of crude N-(3-(5-(thiazol-2-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)methacrylamide (38 mg, 0.076 mmol) in DCM (1.0 mL), was added TFA (1.0 mL). The resulting solution was stirred at room temperature for approximately 3 hours before being concentrated in vacuo. The crude residue was then taken up into MeOH (1.0 mL) and ammonium hydroxide (1.0 mL) was added, and the resulting mixture was stirred at room temperature for approximately 30 minutes. The reaction was concentrated to afford a crude solid that was dissolved in a mixture of MeOH and EtOAc, filtered through 2 Stratospheres™ PL-HCO3 MP SPE cartridges, concentrated in vacuo and purified by reverse phase HPLC using an acetonitrile gradient in water with 0.1% TFA modifier. Lyophyllization of the desired fractions afforded N-(3-(5-(thiazol-2-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)methacrylamide as an off-white solid. LRMS (ESI) calcd for C19H15N5OS [M+H]+: 362, found 362. 1H NMR (600 MHz, DMSO-d6) δ 12.93 (s, 1H), 9.75 (s, 1H), 8.92 (s, 1H), 8.10 (d, J=2.4 Hz, 1H), 7.91 (s, 1H), 7.69 (d, J=7.8 Hz, 1H), 7.55 (m, 2H), 7.07 (t, J=7.8 Hz, 1H), 6.91 (d, J=7.8 Hz, 1H), 5.74 (s, 1H), 5.47 (s, 1H), 1.90 (s, 3H).
Workup
- concentrationbefore being concentrated in vacuo
- additionwas added
- stirringthe resulting mixture was stirred at room temperature for approximately 30 minutes
- concentrationThe reaction was concentrated
- customto afford a crude solid
- filtrationfiltered through 2 Stratospheres™ PL-HCO3 MP SPE cartridges
- concentrationconcentrated in vacuo
- custompurified by reverse phase HPLC
Sources & evidence
- ORD record
- ord-7af0f5614b3f4fb4ad646cdb796ede1d
- Source dataset
- uspto-grants-2015_03
- Patent number
- US08993756B2
Reaction notes
Loading…